Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Common-Size Balance Sheet: Assets

Paying users area

The data is hidden behind: . Unhide it.

  • Get 1-month access to Celgene Corp. for $22.49, or

  • get full access to the entire website for at least 3 months from $62.19.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Celgene Corp., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Cash and cash equivalents
Debt securities available-for-sale
Equity investments with readily determinable fair values
Marketable securities available-for-sale
Accounts receivable, net of allowances
Inventory
Income tax receivable
Other receivables
Derivative assets
Other prepaid taxes
Prepaid income taxes
Prepaid maintenance and software licenses
Other
Other current assets
Current assets
Property, plant and equipment, net
Intangible assets, net
Goodwill
Other non-current assets
Non-current assets
Total assets

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Celgene Corp. current assets as a percentage of total assets increased from 2016 to 2017 but then decreased significantly from 2017 to 2018.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Celgene Corp. property, plant and equipment, net as a percentage of total assets increased from 2016 to 2017 and from 2017 to 2018.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Celgene Corp. non-current assets as a percentage of total assets decreased from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.